Antihyperglycemic properties of hydroxychloroquine in patients with diabetes: Risks and benefits at the time of COVID-19 pandemic [0.03%]
羟氯喹在糖尿病患者中的抗高血糖性质：COVID-19大流行期间的利弊分析
Marco Infante,Camillo Ricordi,Andrea Fabbri
Marco Infante
The antimalarial drug hydroxychloroquine (HCQ) has long been used as a disease-modifying antirheumatic drug for the treatment of several inflammatory rheumatic diseases. Over the last three decades, various studies have shown that HCQ also ...
COVID-19 and comorbidities: A role for dipeptidyl peptidase 4 (DPP4) in disease severity? [0.03%]
冠状病毒病2019合并症：DPP4在疾病严重性中扮演角色？
Margaret F Bassendine,Simon H Bridge,Geoffrey W McCaughan et al.
Margaret F Bassendine et al.
The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel betacoronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), similar to SARS-CoV and Middle East respiratory syndrome (MERS-CoV), which cause acute resp...
Do novel drugs for diabetes help in COVID-19? Another brick in the wall? [0.03%]
新糖尿病药物对新冠肺炎有效吗？再添一块砖还是多馀的累赘？
Alicja Krejner-Bienias,Katarzyna Grzela,Tomasz Grzela
Alicja Krejner-Bienias
Home-based training strategy to maintain muscle function in older adults with diabetes during COVID-19 confinement [0.03%]
新冠肺炎疫情期间社区糖尿病老人肌肉功能维持的居家训练策略研究
Amelia Guadalupe-Grau,Olga López-Torres,Álvaro Martos-Bermúdez et al.
Amelia Guadalupe-Grau et al.
Joint impact of muscle mass and waist circumference on type 2 diabetes in Japanese middle-aged adults: The Circulatory Risk in Communities Study (CIRCS) [0.03%]
日本中年人群肌肉量与腰围对2型糖尿病联合影响的流行病学研究：社区心血管风险研究（CIRCS）项目数据
Mikako Yasuoka,Isao Muraki,Hironori Imano et al.
Mikako Yasuoka et al.
Background: Although evidence about skeletal muscle mass loss and type 2 diabetes risk has accumulated, little information is available on the combined effect of skeletal muscle mass and abdominal obesity on type 2 diabet...
Zachary Bloomgarden
Zachary Bloomgarden
Patient characteristics and 6-month dose of basal insulin associated with HbA1c achievement <7.0% in Chinese people with type 2 diabetes: results from the Observational Registry of Basal Insulin Treatment (ORBIT) [0.03%]
与HbA1c达标相关的患者特征和基础胰岛素的6个月剂量
Leili Gao,Puhong Zhang,Jianping Weng et al.
Leili Gao et al.
Background: The efficacy of basal insulin (BI) for adequate glycemic control in patients with type 2 diabetes mellitus (T2DM) has been well documented by randomized clinical trials. This post hoc analysis of the Observati...
Observational Study
Journal of diabetes. 2020 Sep;12(9):668-676. DOI:10.1111/1753-0407.13046 2020
Weiqing Wang,Jieli Lu,Weiqiong Gu et al.
Weiqing Wang et al.
GLP-1 and insulin regulation of skeletal and cardiac muscle microvascular perfusion in type 2 diabetes [0.03%]
GLP-1和胰岛素对2型糖尿病骨骼肌和心肌微血管灌注的调节作用
Kaitlin M Love,Jia Liu,Judith G Regensteiner et al.
Kaitlin M Love et al.
Muscle microvasculature critically regulates skeletal and cardiac muscle health and function. It provides endothelial surface area for substrate exchange between the plasma compartment and the muscle interstitium. Insulin fine-tunes muscle ...
Frequency, clinical characteristics, and determinants of partial remission in type 1 diabetes: Different patterns in children and adults [0.03%]
1型糖尿病的不完全缓解：频率、临床特征及其决定因素——儿童与成人模式不同
Ting Zhong,Rong Tang,Yuting Xie et al.
Ting Zhong et al.
Background: Partial remission (PR) is a special stage in type 1 diabetes (T1D). The different patterns of PR frequency, characteristics, and determinants in juvenile and adult patients are unclear, and data on Chinese are...
Comparative Study
Journal of diabetes. 2020 Oct;12(10):761-768. DOI:10.1111/1753-0407.13044 2020